Derma Sciences, Inc. · Princeton, NJ United States (NASDAQ: DSCI)
Key Derma Sciences, Inc. Financials
| Company Type | Public -(NASDAQ: DSCI) Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2000 Sales (mil.) | $9.6 |
| 2010 Employees | 195 |
Derma Sciences, Inc. Income Statement
| Dec 00 | Dec 99 | Dec 93 | |
| Revenue | 9.6 | 10.1 | 4.1 |
| Cost of Goods Sold | 4.6 | 4.0 | -- |
| Gross Profit | 5.0 | 6.1 | 4.1 |
| Gross Profit Margin | 52.3% | 60.4% | -- |
| SG&A Expense | 6.0 | 8.3 | -- |
| Depreciation & Amortization | 0.4 | 0.2 | -- |
| Operating Income | (1.4) | (2.4) | -- |
| Operating Margin | -14.4% | -23.8% | --% |
| Nonoperating Income | (0.1) | -- | -- |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | -- | -- | -- |
| Income Taxes | -- | -- | -- |
| Net Income After Taxes | 0.0 | 0.0 | 0.0 |
| Continuing Operations | (1.4) | (2.4) | -- |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (1.4) | (2.4) | -- |
| Total Net Income | (1.4) | (2.4) | 0.2 |
| Net Profit Margin | -15% | -23.8% | 4.9% |
| Diluted EPS from Total Net Income | (6.56) | (14.72) | 0.08 |
| Dividends per Share | -- | -- | 0.0 |
All amounts in millions of US Dollars except per share amounts.
Derma Sciences, Inc. Balance Sheet
| Assets | Dec 00 | Dec 99 | Dec 93 |
| Current Assets | |||
| Cash | 1.1 | 1.2 | 0.1 |
| Net Receivables | 1.6 | 2.0 | -- |
| Inventories | 1.3 | 1.3 | -- |
| Other Current Assets | 0.1 | 0.3 | -- |
| Total Current Assets | 4.0 | 4.8 | -- |
| Net Fixed Assets | 0.2 | 0.4 | -- |
| Other Noncurrent Assets | 1.4 | 1.6 | -- |
| Total Assets | 5.6 | 6.8 | 1.9 |
| Liabilities | Dec 00 | Dec 99 | Dec 93 |
| Current Liabilities | |||
| Accounts Payable | 1.0 | 1.3 | -- |
| Short-Term Debt | 0.6 | 0.7 | -- |
| Other Current Liabilities | 0.5 | 0.4 | -- |
| Total Current Liabilities | 2.1 | 2.4 | -- |
| Long-Term Debt | 0.5 | 1.3 | 0.0 |
| Other Noncurrent Liabilities | 0.0 | 0.0 | -- |
| Total Liabilities | 2.6 | 3.7 | -- |
| Shareholder's Equity | |||
| Preferred Stock Equity | 0.0 | -- | -- |
| Common Stock Equity | 3.0 | 3.1 | -- |
| Total Equity | 3.0 | 3.1 | -- |
| Shares Outstanding (thou.) | 6,561.8 | 5,039.5 | 3.2 |
All amounts in millions of US Dollars except per share amounts.
Derma Sciences, Inc. Cash Flow Statement
| Dec 00 | Dec 99 | Dec 93 | |
| Net Operating Cash Flow | (1) | (3) | -- |
| Net Investing Cash Flow | (0.0) | (0.1) | -- |
| Net Financing Cash Flow | 0.4 | 1.7 | |
| Net Change in Cash | (0.2) | (1.1) | |
| Depreciation & Amortization | 0.4 | 0.2 | |
| Capital Expenditures | (0.0) | (0.1) | |
| Cash Dividends Paid |
All amounts in millions of US Dollars except per share amounts.